Figure 4.
Therapeutic studies for 90Y-DOTA-UPSN. (A) Tumor growth curves. *Significantly smaller relative tumor volumes found for the group of mice injected with 90Y-DOTA-UPSN when compared to all other groups (p < 0.05, n = 5). (B) Overall survival curve demonstrating significant extension in median survival in the group treated with 90Y-DOTA-UPSN.